Ainos (AIMD) Reports Q2 Results

Go back to Ainos (AIMD) Reports Q2 Results

Ainos Reports Second Quarter 2023 Financial Results

August 11, 2023 4:31 PM EDT

Strategic Focus Continues to Pivot from COVID to Pet Health and AI-powered Testing

Launch of VELDONA Pet Provides New Revenue Stream for Near-Term; Ainos Flora Remains on Horizon for 2024

SAN DIEGO, CA / ACCESSWIRE / August 11, 2023 / Ainos, Inc. (NASDAQ:AIMD, AIMDW) ("Ainos", or the "Company"), a diversified healthcare company focused on the development of novel point-of-care testing, low-dose interferon therapeutics, and synthetic RNA-driven preventative medicine, today announced its financial results for the second quarter ended June 30, 2023.

Chun-Hsien (Eddy) Tsai, Chairman of the Board, President, and Chief Executive Officer of... More